Just got off the phone from Macquarie Analyst on Medibank. The facts summary as follows as per him
1. Instos demand can be many times more than what is available to them
2. No chance of closing earlier than Next Tue Broker Firm deadline
3. No debt and $2.2 Bil cash and absolutely no risk like other insurers and will expand into other areas
4. Some fat has been cut already in the last 2 years but can be more leaner and meaner
5. Possibility of final price being towards the top end of the range but most likely not above the range
6. Highly unlikely to take the 20% claw back from Broker firm Retail allocations
7. Should do very well straight after listing with the instos demand to meet the S&P Index Requirements.
So it appears it will be priced around at least $1.80 by the sound of it! well another 5 days to chew about!!!!
